期刊文献+

白细胞介素-28B基因多态性与原发性肝细胞肝癌的关系 被引量:4

Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma
原文传递
导出
摘要 目的探讨白细胞介素-28B(IL-28B)基因不同位点SNP与原发性肝细胞肝癌的关系。方法以2001年i1月至2010年4月就诊于桂林某医院和北京某医院的肝癌患者作为病例组,共300例,其中有139例患者具有完整的临床追踪资料;选取2009--2010年于上述两所医院中进行健康体检,且无肿瘤及慢性乙型肝炎疾病史者作为对照组,共310名;研究对象均为汉族,无年龄、性别限制。经知情同意,每名研究对象采集外周血2ml,采用质谱分析法对研究对象IL-28B基因rs12972991、rs8099917、rs12979860和rs4803223等位点SNP进行分析。结果病例组rs12972991位点c等位基因、rs8099917位点G等位基因和rs4803223位点G等位基因频率分别是6.7%(40/598)、7.9%(47/598)、10.0%(59/588);对照组分别为2.9%(18/618)、4.1%(25/616)、3.6%(21/608),病例组均高于对照组,差异有统计学意义(X2值分别为9.542、7.858、20.736,P值均〈0.05);携带上述等位基因可增加原发性肝细胞肝癌的患病风险[OR(95%CI)值分别为1.67(1.13~2.46)、1.49(1.08~2.06)、2.91(1.79~4.72)]。病例组rs12972991位点AC+CC基因型、rs8099917位点GT+GG基因型和rs4803223位点GA+GG基因型频率分别为13.0%(39/299)、14.7%(44/299)、19.0%(56/296);对照组分别为5.8%(18/309)、8.1%(25/308)、6,6%(20/304),病例组均高于对照组,差异有统计学意义(X2值分别为9.319、6.557、20.948,P值均〈0.05);携带上述基因型可增加原发性肝细胞肝癌的患病风险[OR(95%C/)值分别为2.24(1.31—3.83)、1.81(1.14~2.88)、2.90(1.78~4.70)]。对患者临床资料分析发现,出现门静脉癌栓的患者rs4803223位点GA+GG基因型频率为50.0%(13/26),高于AA基因型频率[21.1%(23/109)],差异有统计学意义(X2=8.965,P=0.003)。结论IL-28B基因多态性与原发性肝细胞肝癌患病存在关联,其中携带rs4803223位点GA+GG基因型可增加原发性肝细胞肝癌患者门静脉癌栓的发生风险。 Objective To explore the correlation between single nucleotide polymorphisms (SNPs) of interleukin-28B (IL-28B) gene and the susceptibility to primary hepatocellular carcinoma (HCC). Methods A total of 300 histologically confirmed HCC cases (from November 2001 to April 2010) and 310 healthy controls with no history of chronic hepatitis B or hepatocellular carcinoma (2009 - 2010) were selected from a hospital in Guilin and a hospital in Beijing for this case-control study. 139 HCC patients in the case group had complete clinical tracking data. All the subjects were Han Chinese, with no age or gender restrictions. 2 ml peripheral blood samples were drawn from each subject with informed consent. SNP of rs12972991, rs4803223, rs8099917 and rs12979860 four loci in IL-28B gene were analyzed by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF). Results The frequencies of C allele at rs12972991, G allele at rs8099917 and G allele at rs5803223 were 6. 7% (40/ 598), 7.9% (47/598) and 10.0% (59/588) respectively in case group; all higher than the corresponding frequencies in control group, separately 2. 9% ( 18/618), 4. 1% (25/616) and 3.6% (21/608). The differences were statistically significant ( x2 = 9. 542, 7. 858, 20. 736, P values all 〈 0. 05 ). The above alleles could increase the risk of HCC, and the OR(95% CI) values were separately 1.67 (1.13 -2. 46), 1.49( 1.08 -2. 06) and 2. 91 ( 1.79 -4. 72). The genotype frequencies of AC + CC at rs12972991, GT + GG at rs8099917, GA + GG at rs4803223 were 13.0% (39/299), 14. 7% (44/299) and 19.0% (56/296) respectively in ease group; while the frequencies were lower in control group, separately 5.8% (18/309) , 8. 1% (25/308) and 6. 6% (20/304). The differences were statistieally significant ( X2 = 9.319, 6. 557, 20. 948, P values all 〈 0.05 ) . These genotypes may increase the risk of HCC, and the adjusted OR (95%C1) values were 2. 24 (1.31 - 3.83), 1.81 (1.14 - 2. 88) and 2. 90 ( 1.78 - 4. 70), respectively. The stratified analysis of the elinical data indicated that the frequeney of genotype GA + GG at rs4803223 was 50. 0% (13/26) in patients of tumor thrombosis in portal vein (TTPV), higher than the frequency of genotype AA (21.1% , 23/109). The difference was statistically significant (x2 = 8. 965, P = 0.003). Conclusion The results suggested that IL-28B gene polymorphisms was correlated to the susceptibility to HCC in Chinese Han ethnic population. Among them, GA + GG genotype at rs4803223 could increase the risk of TTPV in HCC patients.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2012年第6期527-532,共6页 Chinese Journal of Preventive Medicine
基金 基金项目:国家自然科学基金(91029741,81001072) 国家“十一五”科技重大专项(2008ZX10002-019)
关键词 肝肿瘤 多态性 单核苷酸 白细胞介素类 Liver neoplasms Polymorphism, single nueleotide Interleukins
  • 相关文献

参考文献4

二级参考文献71

  • 1陈曲波,范列英,仲人前,屠小卿,袁媛,朱烨,叶伟民,陆慧琦,韩焕兴.白细胞介素-10基因多态性与自身免疫性肝病相关性研究[J].中华肝脏病杂志,2004,12(6):356-359. 被引量:5
  • 2龚晓红,王富珍,李辉,刘立荣,李阳桦,王宝兰,李立琴,张震,韩庆英,唐耀武.北京市儿童乙型肝炎疫苗接种12年后免疫效果观察[J].中华预防医学杂志,2005,39(4):265-268. 被引量:59
  • 3Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their elass II eytokine receptor IL-28R. Nature Immunol, 2003, 4 ( 1 ) :63-68.
  • 4Lasfar A, Lewis-Antes, Kotenko S V, et al. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma, Cancer Rcs, 2006,66 ( 8 ) :4468-4477.
  • 5Chen Q, Carroll H P, Gadina M. The newest interleukins:recent additions to the ever-growing cytokine family. Vitam Honn, 2006,74 : 207 -228.
  • 6Dumoutier L, Renauld J C. Viral and cellular intedeukin-10( IL- 10) -related cytokines : from structures to functions. Eur Cytokine New, 2002,13( 1 ) :5-15.
  • 7Berghall H, Siren J, Sarkar D, et al. The interferon-inducible RNA helicase is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect, 2006,8 (8) :2138-2144.
  • 8Brand S, Beigel F, Olszak T, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol, 2005,289 (5) :960-968.
  • 9Siren J, Pirhonen J, Julkunen I, et al. IFN-α regulates TLR- dependent gene expression of IFN-α, IFN-β, IL-28, and IL-29. J. Immunol. 2005,174(4) :1932-1937.
  • 10Coccia E M, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ. interferons in human plasmacytoid and monocyte-derived dendritic ceils. Eur J Immunol, 2004,34 (3) :796-805.

共引文献1045

同被引文献36

  • 1贺菽嘉,顾永耀,廖志红.Ⅱ相代谢酶基因多态性联合烟酒习惯对肝癌易感性的影响[J].基础医学与临床,2007,27(6):666-669. 被引量:4
  • 2Jemal A,Bray F, Melissa M,et al.Global cancer statistics[J].CA CANCER JCLIN,2011,61(2):69-90.
  • 3Stewart BW,Wild CP.Word cancer report 2014[M].Lyon: International Agency for Research on Cancer,2014.
  • 4Sanyal AJ, Yoon SK,Lencioni R.The etiology of hepatocellular carcinoma and consequences for treatment[J].Oncologist, 2010,15(Suppl 4):14-22.
  • 5Zhang H,Zhai Y, Hu Z,et al.Genome-wide association study identifies lp36.22 as a new susceptibility locus forhepatocellular carcinoma in chronic hepatitis B virus carriers [J].Nature Genetics,2010,42(9):755-758.
  • 6Sopipong W,Tangkijvanich P,Payungporn S,et al.The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai Patients[J].Asian Pac J Cancer Prev,2013,14(5):2865-2869.
  • 7中华人民共和国卫生部.卫生部办公厅关于印发《原发性肝癌诊疗规范(2011年版)》的通知[EB/OL].[2014-10-01].http://www.moh.gov.cn/mohyzs/s3586/201110/53153.shtml.
  • 8Nangaku M,Sato-Yoshitake R,Okada Y,et al.KIF1B,a novel microtubule plus end-directed monomeric motor protein for transport of mitocbondria[J].Cell, 1994,79(7): 1209-1220.
  • 9Midorikawa Y,Yamamoto S,Tsuji S,et al.Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis[J].14epatology,2009,49:513-522.
  • 10Bagchi A,Mills AA.The quest for the lp36 tumor suppressor [J].Cancer Res,2008,68(8):2551-2556.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部